相关报告 1.【华安化工】基础化工：蓝星收购 埃肯有机硅资产，我国首个生物燃油 2.【华安化工】染料产业链格局改善， 3.【华安化工】合成生物学周报：工 （1）有机硅行业盈利步入修复通道，新兴应用领域成为核心增长引 擎。2019—2024 年，国内有机硅 DMC 产能高速扩张，引发行业阶段 性产能过剩，市场价格持续下行。2025 年，行业无新增产能落地，叠 加海外产能持续出清，供给端增速正式见顶。需求侧，新能源汽车、 光伏等新兴领域需求维持高速增长态势，叠加出口量同比提升，行业 供需格局显著改善。在此背景下，行业头部企业牵头召开行业发展研 讨会，就有机硅产品达成动态定价机制与减产协议，推动行业盈利进 入修复周期。相关公司：合盛硅业、兴发集团相关公司。 [Table_StockName基Rpt础Typ化e] 工 行业周报 美国将磷列为国防关键物资，原油、TDI、染料等价格上涨 行业评级： 增持 报告日期： 2026-03-02 [T行ab业le_周Su观m点mary] 公司价格与沪深 300 走势比较 本周（2026/02/23-2026/02/27）化工板块整体涨跌幅表现排名 第 3 位，涨跌幅为 7.15% ...

Investment Rating - The report maintains an "Optimistic" rating for the chemical industry [4][5]. Core Insights - The geopolitical conflict between the US and Iran is expected to drive up prices for methanol, ethylene glycol, and urea, with a comprehensive price increase anticipated for chemical products after the holiday [4]. - The report highlights the impact of differentiated electricity pricing in Shaanxi, which may accelerate the exit of outdated production capacities and improve industry dynamics [4]. - The overall capital expenditure in the chemical sector is at its peak, with low inventory levels in the supply chain, suggesting a favorable environment for price increases as downstream production resumes post-holiday [4]. Industry Dynamics - Current macroeconomic judgment indicates that oil prices are expected to remain in a relatively loose range, with Brent crude projected between $60 and $75 per barrel due to delayed OPEC+ production increases and stable demand recovery [5]. - Coal prices are expected to stabilize at a low level in the medium to long term, while natural gas costs may decrease as the US accelerates its export facility construction [5]. - The report notes that the January PPI for industrial products decreased by 1.4% year-on-year but increased by 0.4% month-on-month, indicating a slight recovery in the manufacturing sector [7]. Investment Analysis - The report suggests focusing on four main areas for investment: 1. Textile and apparel chain, benefiting from high demand growth and improved supply dynamics [4]. 2. Agricultural chemicals, with stable fertilizer demand and increasing transgenic penetration supporting long-term pesticide demand [4]. 3. Export-related chemical products, as overseas inventories are at historical lows and interest rates are expected to decline [4]. 4. "Anti-involution" policies leading to accelerated clearance of outdated capacities in various sectors [4]. Key Material Focus - The report emphasizes the importance of self-sufficiency in key materials, particularly in semiconductor and panel materials, as well as in lithium battery and fluorine materials [4].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 本公告所载2025年度主要财务数据为初步核算数据，未经会计师事务所审计，具体数据以上海凯赛生物 技术股份有限公司（以下简称"公司"）2025年年度报告为准，提请投资者注意投资风险。 一、2025年度主要财务数据和指标 单位：万元 ■ 注：1.以上财务数据及指标以未审计的合并报表数据填列； 2.以上表格中数据尾差为数据四舍五入所致。 二、经营业绩和财务状况情况说明 （一）报告期的经营情况、财务状况及影响经营业绩的主要因素 1、2025年度公司实现营业收入329,544.89万元，同比上升11.41%；实现利润总额63,150.35万元，同比 上升15.23%；实现归属于上市公司股东的净利润56,572.04万元，同比上升15.70%,归属于上市公司股东 的扣除非经常性损益的净利润52,592.04万元，同比上升13.17%，基本每股收益0.83元/股，同比下降 1.19%，加权平均净资产收益率3.52%，同比减少0.79个百分点。 2、2025年末公司总资产2,389,970. ...

证券日报网讯 2月27日，凯赛生物发布2025年度业绩快报公告称，公司2025年度实现营业收入329544.89 万元，同比上升11.41%；实现归属于上市公司股东的净利润56572.04万元，同比上升15.70%。 （编辑 王雪儿） ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码：688065 证券简称：凯赛生物 公告编号：2026-001 上海凯赛生物技术股份有限公司 2025 年度业绩快报公告 本公告所载2025年度主要财务数据为初步核算数据，未经会计师事务所审 计，具体数据以上海凯赛生物技术股份有限公司（以下简称"公司"）2025年年 度报告为准，提请投资者注意投资风险。 一、2025 年度主要财务数据和指标 单位：万元 | 科目 | 本期数 | 上年同期 | 增减变动幅度（％） | | --- | --- | --- | --- | | 营业收入 | 329,544.89 | 295,791.16 | 11.41 | | 营业利润 | 63,509.18 | 55,156.12 | 15.14 | | 利润总额 | 63,150.35 | 54,801.52 | 15.23 | | 归属于上市公司股东的净利润 | 56,572.04 | 48,896.19 | 15.70 | | 归属于上市公司股东的扣除非 经常性损益的净利润 | 5 ...

凯赛生物晚间公告，2025年度公司实现营业收入32.95亿元，同比上升11.41%；实现利润总额6.32亿 元，同比上升15.23%；实现归属于上市公司股东的净利润5.66亿元，同比上升15.70%；归属于上市公司 股东的扣除非经常性损益的净利润5.26亿元，同比上升13.17%。 ...

Investment Rating - The industry investment rating is upgraded to "Overweight" [3] Core Insights - The chemical industry is expected to experience a recovery driven by both cyclical and growth factors, with a focus on organic silicon, PTA, polyester filament, caprolactam, spandex, vitamins, sweeteners, refrigerants, and phosphorus chemicals [7] - The organic silicon industry is entering a recovery phase, with new applications becoming the core growth driver. From 2019 to 2024, domestic DMC capacity expanded rapidly, leading to temporary oversupply and declining prices. However, with no new capacity expected in 2025 and increasing demand from sectors like new energy vehicles and photovoltaics, the supply-demand balance is improving [7] - The PTA and polyester filament industries are approaching a turning point, with the expansion cycle nearing its end. The demand side is expected to continue growing, supported by easing trade tensions and improved external demand [7] - The introduction of quota policies is expected to lead refrigerants into a high prosperity cycle, with supply constraints and stable demand growth from markets like heat pumps and cold chain logistics [9] - The synthetic biology sector is poised for explosive growth, driven by the transition to low-energy products and breakthroughs in non-grain bio-based materials [9] - OLED technology is accelerating its penetration into various display sizes, supported by policy measures aimed at fostering the new display industry [10] - The demand for high-frequency and low-loss electronic resins is increasing due to the rise of AI infrastructure, with AI server shipments expected to grow significantly [11] - The electronic chemicals sector is benefiting from the expansion of wafer production capacity, with increasing demand for key materials like photoresists and packaging materials [12] Summary by Sections Industry Performance - The chemical sector's overall performance ranked 14th with a weekly change of 0.78%, outperforming the Shanghai Composite Index by 0.38 percentage points [6][21] - Key stocks such as Honghe Technology and Zhongcai Technology saw significant price increases due to rising demand in AI servers and high-speed network equipment [6] Supply-Side Tracking - A total of 155 companies in the chemical industry had their production capacities affected, with 4 new repairs and 7 restarts reported [14] Key Industry Dynamics - BlueStar announced the acquisition of Elkem's core organic silicon assets, marking a strategic move to enhance its position in the global organic silicon industry [34] - The first biofuel blending policy in China was approved, allowing for local blending and reducing reliance on imports [34]

Investment Rating - The report maintains a "Positive" rating for the chemical industry [4][3]. Core Insights - The macroeconomic outlook for the chemical industry indicates a stable increase in oil demand due to global economic recovery and tariff adjustments, with Brent crude oil expected to remain in the range of $60-75 per barrel [4][5]. - The report highlights a potential spring boom in the chemical sector, driven by the success of domestic robotics showcased during the Spring Festival and favorable export conditions following tariff reductions [4][3]. - Investment opportunities are identified in various chains, including textiles, agricultural chemicals, and overseas real estate, with specific companies recommended for investment [4][3]. Industry Dynamics - Oil supply is tightening due to OPEC+ production delays and peak shale oil output, while demand is stabilizing with improved global economic conditions [5]. - The chemical industry is at a cyclical turning point, with downstream operations gradually resuming post-holiday, indicating a positive demand outlook for the year [4][3]. - The report notes that the Producer Price Index (PPI) for industrial products decreased by 1.4% year-on-year in January, while the manufacturing PMI recorded 49.3, indicating some volatility in manufacturing activity [7][4]. Investment Analysis - The report suggests a diversified investment strategy focusing on four key areas: textiles, agricultural chemicals, export chains, and beneficiaries of "anti-involution" policies [4][3]. - Specific companies to watch include those in the textile chain like Lu Xi Chemical and Tongkun Co., and in the agricultural chain like Hualu Hengsheng and Baofeng Energy [4][3]. - The report emphasizes the importance of self-sufficiency in key materials, particularly in semiconductor and panel materials, recommending companies such as Yake Technology and Ruilian New Materials [4][3].

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting it as a new growth point for optimizing industrial structure and transforming economic models [1]. Group 1: Current Status and Trends - The "2025 China Synthetic Biomanufacturing Industry Development White Paper" was officially released on August 1, highlighting the current state and trends of biomanufacturing [1]. - The report analyzes the global biomanufacturing industry, including key platform facilities and a comparative study of the US and China in this sector [7]. Group 2: Policy Landscape - The white paper outlines major domestic and international policies affecting biomanufacturing from 2024 to 2025, providing insights into regulatory frameworks [7]. Group 3: Industry Map and Applications - It presents a comprehensive map of the Chinese biomanufacturing industry and identifies key application areas, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [7]. Group 4: Key Enterprises - The report selects ten leading enterprises in the Chinese biomanufacturing sector and details the strategic directions of 15 listed companies in synthetic biology [7][8]. Group 5: Investment and Challenges - The document discusses the investment landscape in synthetic biology from 2024 to mid-2025 and addresses the challenges faced by the biomanufacturing industry in China, along with proposed countermeasures [7].

Group 1 - The core viewpoint of the articles highlights the collaboration between the company and China Merchants Group to advance the commercialization of bio-based new materials in various sectors such as highways, bridges, construction, containers, and ships [1] - The company is accelerating the testing and product validation work, aiming to expand commercialization channels through demonstration projects [1] - The company's core development directions for the next 3-5 years include the research and development of high-value utilization technology for biomass waste, the expansion of bio-based polyamide and its composite materials, and the construction of an industrial ecosystem [1] Group 2 - The company has adjusted the expected operational status date for its "annual production of 500,000 tons of bio-based hexamethylenediamine and 900,000 tons of bio-based polyamide project" from December 31, 2025, to December 31, 2027, while the project construction content remains unchanged [2]